These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 1325078)

  • 1. Comparison of recombinant tissue factor pathway inhibitors expressed in human SK hepatoma, mouse C127, baby hamster kidney, and Chinese hamster ovary cells.
    Wun TC; Kretzmer KK; Palmier MO; Day KC; Huang MD; Welsch DJ; Lewis C; Wolfe RA; Zobel JF; Lange GW
    Thromb Haemost; 1992 Jul; 68(1):54-9. PubMed ID: 1325078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tissue factor pathway inhibitor: the carboxy-terminus is required for optimal inhibition of factor Xa.
    Wesselschmidt R; Likert K; Girard T; Wun TC; Broze GJ
    Blood; 1992 Apr; 79(8):2004-10. PubMed ID: 1562726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Refold and characterization of recombinant tissue factor pathway inhibitor expressed in Escherichia coli.
    Diaz-Collier JA; Palmier MO; Kretzmer KK; Bishop BF; Combs RG; Obukowicz MG; Frazier RB; Bild GS; Joy WD; Hill SR
    Thromb Haemost; 1994 Mar; 71(3):339-46. PubMed ID: 8029799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The carboxy terminus of tissue factor pathway inhibitor is required for interacting with hepatoma cells in vitro and in vivo.
    Warshawsky I; Bu G; Mast A; Saffitz JE; Broze GJ; Schwartz AL
    J Clin Invest; 1995 Apr; 95(4):1773-81. PubMed ID: 7706485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteolysis of tissue factor pathway inhibitor (TFPI) by plasmin: effect on TFPI activity.
    Li A; Wun TC
    Thromb Haemost; 1998 Sep; 80(3):423-7. PubMed ID: 9759622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoaffinity purification and characterization of lipoprotein-associated coagulation inhibitors from Hep G2 hepatoma, Chang liver, and SK hepatoma cells. A comparative study.
    Wun TC; Huang MD; Kretzmer KK; Palmier MO; Day KC; Bulock JW; Fok KF; Broze GJ
    J Biol Chem; 1990 Sep; 265(27):16096-101. PubMed ID: 2168880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low risk of inhibitor formation in haemophilia patients after a change in treatment from Chinese hamster ovary cell-produced to baby hamster kidney cell-produced recombinant factor VIII.
    Singleton E; Smith J; Kavanagh M; Nolan B; White B
    Thromb Haemost; 2007 Dec; 98(6):1188-92. PubMed ID: 18064312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant tissue factor pathway inhibitor enhances the binding of factor Xa to human monocytes.
    Li A; Chang AC; Peer GT; Wun TC; Taylor FB
    Thromb Haemost; 2001 May; 85(5):830-6. PubMed ID: 11372676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antithrombotic effect of human recombinant tissue factor pathway inhibitor on endotoxin-induced intravascular coagulation in rats: concerted effect with antithrombin.
    Kamikubo Y; Hamuro T; Matsuda J; Shinya N; Miyamoto S; Funatsu A; Kato H
    Thromb Haemost; 1996 Oct; 76(4):621-6. PubMed ID: 8903006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitory properties of a novel human Kunitz-type protease inhibitor homologous to tissue factor pathway inhibitor.
    Petersen LC; Sprecher CA; Foster DC; Blumberg H; Hamamoto T; Kisiel W
    Biochemistry; 1996 Jan; 35(1):266-72. PubMed ID: 8555184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The recombinant C-terminus of the human MUC2 mucin forms dimers in Chinese-hamster ovary cells and heterodimers with full-length MUC2 in LS 174T cells.
    Lidell ME; Johansson ME; Mörgelin M; Asker N; Gum JR; Kim YS; Hansson GC
    Biochem J; 2003 Jun; 372(Pt 2):335-45. PubMed ID: 12597771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological profiling of recombinant tissue factor pathway inhibitor.
    Jeske W; Hoppensteadt D; Callas D; Koza MJ; Fareed J
    Semin Thromb Hemost; 1996; 22(2):213-9. PubMed ID: 8807720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Establishment of a cell line expressing recombinant factor VII and its subsequent conversion to active form FVIIa through hepsin by genetic engineering method.
    Halabian R; Roudkenar MH; Esmaeili NS; Masroori N; Roushandeh AM; Najafabadi AJ
    Vox Sang; 2009 May; 96(4):309-15. PubMed ID: 19175565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Internalization and degradation of recombinant human coagulation factor VIIa by the human hepatoma cell line HuH7.
    Chang GT; Kisiel W
    Thromb Haemost; 1995 Feb; 73(2):231-8. PubMed ID: 7792735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Total body and hepatic clearance in rats of recombinant tissue-type plasminogen activator expressed in mouse C127 and Chinese hamster ovary cells.
    Hori R; He YL; Shima T; Inui K; Aoki S; Okumura K; Tanigawara Y
    Drug Metab Dispos; 1992; 20(4):541-6. PubMed ID: 1356732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression, purification, and characterization of human recombinant thrombopoietin in Chinese hamster ovary cells.
    Kaszubska W; Zhang H; Patterson RL; Suhar TS; Uchic ME; Dickinson RW; Schaefer VG; Haasch D; Janis RS; DeVries PJ; Okasinski GF; Meuth JL
    Protein Expr Purif; 2000 Mar; 18(2):213-20. PubMed ID: 10686152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxidized low-density lipoprotein associates strongly with carboxy-terminal domain of tissue factor pathway inhibitor and reduces the catalytic activity of the protein.
    Horie S; Hiraishi S; Hamuro T; Kamikubo Y; Matsuda J
    Thromb Haemost; 2002 Jan; 87(1):80-5. PubMed ID: 11848461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural requirements for tissue factor pathway inhibitor interactions with factor Xa and heparin.
    Wesselschmidt R; Likert K; Huang Z; MacPhail L; Broze GJ
    Blood Coagul Fibrinolysis; 1993 Oct; 4(5):661-9. PubMed ID: 8292716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tissue factor pathway inhibitor: structure, biology and involvement in disease.
    Lwaleed BA; Bass PS
    J Pathol; 2006 Feb; 208(3):327-39. PubMed ID: 16261634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression, purification, and characterization of recombinant human factor X.
    Rudolph AE; Mullane MP; Porche-Sorbet R; Miletich JP
    Protein Expr Purif; 1997 Aug; 10(3):373-8. PubMed ID: 9268685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.